Clin2
NCT06045481Possibly a fitNot yet recruiting

Preventing tick-borne fever with a single antibiotic dose

Relapsing Fever, Tick-Borne

Part of Infections clinical trials.

This trial tests whether a single dose of the antibiotic doxycycline can prevent tick-borne relapsing fever in flight course cadets who are exposed to ticks during field training.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
526 people
Ages
18 years to 30 years
Study type
Interventional

Who can take part

  • You are a cadet in the Israel Air Force flight course.
  • You are not allergic to doxycycline (an antibiotic).
  • You have not had a fever in the past 3 weeks.
  • You have no signs of tick-borne relapsing fever in the past 3 weeks.
  • You completed the full field series.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05972772Recruiting· Phase 2/Phase 3
Test study drugs to clear rickettsia infections

This study tests antibiotics to help your body clear rickettsia-related illnesses like murine typhus or scrub typhus. It may help reduce symptoms and shorten how long you feel sick, based on how well the infection clears.

Vientiane, Vientaine
NCT06611111Recruiting· Early Phase 1
Ceftriaxone for lingering fatigue after Lyme disease

This study tests whether a short course of a strong antibiotic (ceftriaxone) can help people who still have fatigue and other symptoms after being treated for Lyme disease. It aims to see if this treatment can improve your quality of life.

East Syracuse, New York
NCT06477185Recruiting· Phase 2
Preventing lung scarring after TB with doxycycline

This trial tests whether the antibiotic doxycycline can prevent lung scarring (fibrosis) after a serious TB infection. You may be eligible if you are currently being treated for active TB and have significant lung damage on your chest X-ray.

Kampala, Kampala
NCT06738407Recruiting· Phase 4
Doxycycline to prevent STIs in high-risk people

This study tests whether taking a daily antibiotic (doxycycline) can prevent sexually transmitted infections in people at high risk. If you've had an STI recently and sometimes have sex without condoms, you might be able to join.

Los Angeles, California
NCT05036707Recruiting· Phase 1/Phase 2
Study how tick bites change immune responses

This study looks at how a person’s immune system responds after exposure to Ixodes (black-legged) tick bites. It aims to better understand the body’s early immune reaction after tick exposure, using blood tests and small skin samples.

Bethesda, Maryland
NCT04762134Recruiting
Doxycycline to prevent future bacterial STIs in high-risk men

This trial tests whether taking doxycycline can lower the chance of getting bacterial sexually transmitted infections like syphilis, gonorrhea, and chlamydia. It is aimed at men who have had these infections recently and expect to keep having multiple male partners.

Calgary, Alberta

Hear when a new Relapsing Fever, Tick-Borne trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.